
From 2D to 3D: Restoring in vitro liver models functions
In our previous article, we outlined the main in vitro liver models, immortalized cell lines such
In our previous article, we outlined the main in vitro liver models, immortalized cell lines such
In vitro liver models are central to drug discovery and toxicology, enabling controlled evaluation of metabolism,
Liver disease and drug-induced liver injury remain critical challenges in medicine and pharmaceutical development, demanding models
Re-Engineering the Liver Microenvironment In the first article of this series, we discussed the limitations of
The liver organoid is transforming how researchers approach drug discovery and safety testing. As miniature, three-dimensional
Understanding how the body processes fats is central to tackling obesity, type 2 diabetes, and fatty
Breast cancer remains the most common malignancy in women worldwide, and progress in treatment increasingly depends
Breast cancer is the second cancer-related cause of death in women worldwide, therefore it is no
Introduction Microphysiological systems (MPS) are fast becoming a cornerstone of FDA-aligned non-clinical strategy, especially when paired
Introduction Organoid and artificial intelligence approaches are central to the FDA’s roadmap for reducing animal use
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com
All right reserved to © Cherry Biotech 2023